Long‐term safety and efficacy of delgocitinib ointment, a topical Janus kinase inhibitor, in adult patients with atopic dermatitis

Previous studies demonstrated that delgocitinib ointment, a novel topical Janus kinase inhibitor, rapidly improved clinical signs and symptoms of atopic dermatitis (AD) in Japanese adult patients. We sought to evaluate the long‐term safety and efficacy of delgocitinib 0.5% ointment in a 52‐week stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakagawa, Hidemi, Nemoto, Osamu, Igarashi, Atsuyuki, Saeki, Hidehisa, Murata, Ryusei, Kaino, Hironobu, Nagata, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028108/
https://www.ncbi.nlm.nih.gov/pubmed/31820485
http://dx.doi.org/10.1111/1346-8138.15173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028108/
https://www.ncbi.nlm.nih.gov/pubmed/31820485
http://dx.doi.org/10.1111/1346-8138.15173

Ejemplares similares